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Abstract. COVID-19 pandemic has caused a global public 
health emergency resulting in unprecedented individual and 
societal fear and anxiety. The stress surrounding this biothreat 
appears to have clinical implications in all aspects of medi-
cine, both in mental and physical health spheres. The impact 
of COVID-19 related anxiety in Cardiology, Paediatrics, 
Oncology, Dermatology, Neurology and Mental Health and 
how it affects treatments is discussed. Moreover, the need for 
introducing novel communication and therapeutic approaches 











COVID-19 continues its lethal spread globally (1) with detri-
mental effects on public health and social functioning (2,3). 
Previous experience from smaller scale crises shows that they 
significantly affect the health and well‑being of individuals (2). 
Clinical experience from our departments so far, in accordance 
with emerging literature, indicate that there is an association 
between stress surrounding COVID-19 pandemic and precipi-
tation of various diseases, as well as their treatments.
2. Mental health
In any biological disaster fear, uncertainty and stigma prevail 
and they can act as barriers to proper psychiatric care (4). The 
distress and uncertainty caused by the lack of endpoint for the 
COVID-19 pandemic, while treatment is still not in sight, has a 
significant psychological impact on individuals. It can precipi-
tate the emergence of psychopathology, such as depressive 
and anxiety disorders especially among vulnerable groups, 
for instance the elderly, including the particularly vulnerable 
ones from ethnic minority backgrounds (5), and people with 
pre-existing psychiatric or substance abuse problems (2).
Healthcare workers are at increased risk of psychiatric 
morbidities given the increased pressure they deal with (6). In 
particular, fear of contraction due to increased risk of exposure 
to virus, concerns about infecting their loved ones or having 
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to isolate away from them and being involved in ethically 
difficult decisions around resource‑allocation, may cause a 
significant psychological burden on them (2,7,8); all this while 
working amid intense media and public scrutiny.
Furthermore, the lengthy, massive-scale, unprecedented 
social distancing and isolation that we are currently undergoing 
has additive implications; quarantine has been associated with 
negative psychological effects including emotional disturbance, 
depression, stress, low mood, irritability, panic attacks, phobic 
symptoms, insomnia, anger, emotional exhaustion and post-trau-
matic stress symptoms (9) and in extreme cases, suicide (10).
Finally, it is important to consider the stigma and discrimi-
nation towards infected people and their family members (11). 
Stigmatizing attitudes can present in many alternative versions 
and can be fueled by the fear of transmission of infectious 
diseases (12), therefore efforts to tackle the COVID-19 social 
stigma should be a priority amongst mental health profes-
sionals. Previous experience of the psychosocial impact of 
international outbreaks of viral epidemics and large scale 
financial crises, that COVID‑19 is expected to trigger (13), 
underscore the urgent need to design and implement psycho-
social support and intervention programs (4,14); these should 
be considered an integral part of the healthcare strategy for the 
battle against COVID-19.
3. Cardiology
The brain-heart interaction has been long acknowledged as 
a significant factor for various cardiovascular diseases (15). 
Overstimulation of the sympathetic nervous system due to 
physical or emotional stressors has been hypothesized as the 
underlying cause of myocardial infarction, hypertension, arryth-
mias and stress induced/Takotsubo cardiomyopathy (15-17).
COVID‑19 pandemic has posed significant psychological 
strain on the community with emerging cardiovascular impli-
cations. Since our outpatient clinics are carried out solely by 
telecommunication, we have observed a continuous increase 
in telephone contacts from patients with cardiovascular history 
expressing distress and associated worsening of symptoms, in 
particular angina, palpitations and decompensation of heart 
failure (8). Very recent reports, have linked the huge emotional 
pressure caused by COVID-19 to stress induced/Takotsubo 
cardiomyopathy presenting as acute heart failure (18). Even 
though the number of myocardial infarctions would be antici-
pated to be high, given the increased anxiety and stimulation 
of the brain-heart axis, a decrease of almost 50% has been 
reported in Spain (19). However, other researchers alert that this 
finding most likely is unreal, underlying large delays in seeking 
medical help from patients suffering a myocardial infarc-
tion (20). Anxiety to confront SARS-CoV-2 refrains patients 
from visiting healthcare units. Patients are stressed and reluctant 
to be transferred to a COVID-19 hospital during the pandemic, 
which explains the potential delays in treatment for other 
medical problems. Some patients with myocardial infarction 
may not seek care at all, with detrimental consequences (20).
4. Neurology
Although direct, indirect and postinfectious neurological 
complications related to COVID-19 are well established (21), 
it is uncertain whether anxiety related to the recent pandemic 
affects neurological diseases. For the time being this does not 
seem to be the case. For example, stroke incidence is signifi-
cantly decreased in the COVID-19 era (22,23). Furthermore, 
in the case of migraine, recent experience from Italy showed 
that despite the fact that hospitals nowadays are considered 
non-secure places, patients suffering from severe migraine 
(who were under monthly treatment with IV medication) 
seemed to manage to overcome their fear of COVID-19, as they 
neglected the posed traffic restrictions by the government and 
made it to the hospital, in order to have their anti-migraine IV 
treatment administered (24). Thus, it seems that anxiety of 
migraine relapse outweighed anxiety related to COVID-19 
pandemic (24). Finally, in the case of movement disorders, it 
is considered too early to conclude whether there will be long 
term impacts of COVID-19 pandemic on such patients (25). 
Although it is known that stress can unmask or worsen motor 
symptoms and accelerate the rate of dopaminergic cell loss, 
there are also factors that seem to offer protection against the 
detrimental effects of stress. This has been termed ‘resilience’, 
i.e., the ability to maintain or quickly recover mental health 
during and after times of adversity (26).
5. Oncology
The way we treat cancer during these unprecedented times is 
changing. The COVID-19 pandemic has not only changed our 
daily routines but also forced us to reconsider the approach to 
cancer patients. In the event of an overwhelming pandemic, 
many health care systems will implement a triage system 
that would potentially deny critical care treatment to some 
seriously ill patients (27). The novel pandemic has grounded 
several global activities including the provision of health care 
services to people with chronic conditions such as cancer. 
Current evidence suggests that cancer patients with COVID-19 
infection are a vulnerable group, with a higher risk of severe 
illness resulting in intensive care unit admissions or death, 
particularly if they underwent surgery (28). According to the 
American Society of Clinical Oncology (ASCO), ‘There is no 
direct evidence to support changes in cancer regimen during 
the pandemic’ (29). Therefore, routinely stopping anticancer or 
immunosuppressive therapy is not recommended. Currently, 
there are cancellations or postponement of elective cancer 
surgeries and in the coming days radiotherapy appointments 
may also be affected. Newly diagnosed or existing patients 
with cancer who experience chest symptoms may be denied 
care, due to suspicion of COVID-19 infection. For patients 
with cancer, these will have huge repercussions on their expe-
rience and management of cancer-related symptoms, quality 
of life and survival.
Cancer patients are expectedly anxious whether they are 
symptomatic or not, which can sometimes negatively affect 
their genuine desire for life. They require information, coun-
seling, symptomatic control and treatment. They need to be 
supported. Traditionally this is achieved through hospital 
visits, but in the new COVID-19 landscape, this could be 
potentially achieved by telemedicine; it is a matter of urgency 
that we accelerate remote cancer care, by also empowering 
patients and caregivers through effective communication. 
Furthermore, palliation remains an ethical obligation and we 
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should strive for symptom control and comfort care especially 
during the pandemic (30).
6. Paediatrics
Recent data suggest that children are less susceptible to 
COVID-19 infection (31). However, given the large burden 
of anxiety passing from parents and media to children, 
considerable psychological implications have been noted. 
The lockdown of schools and playgrounds, the restriction of 
outdoor activities during physical and social isolation have 
been reported to trigger manifestations of anxiety, such as 
panic attacks and psychosomatic symptoms (8). Reports from 
China unveiled that the most common psychological and 
behavioral problems among children and adolescents were 
clinginess, distraction, irritability, and fear of asking ques-
tions about the epidemic (32). It is also important to note that 
the social isolation and the exhortation to ‘stay at home’ has 
major implications for those children already living in the 
same household with someone who is abusive; unfortunately, 
domestic violence rates are rising fast (33).
Reports on the response of the pediatric population during 
pandemics remain scarce. Psychological stress in children may 
cause anxiety, depression, lethargy, impaired social interaction 
and reduced appetite. Physiological effects include a weakened 
or compromised immune system leading to increased suscep-
tibility to other diseases (32). Communication with children 
to express their concerns, playing collaborative games to alle-
viate loneliness, encouraging physical activity and using music 
therapy can reduce psychological stress (32).
Pediatric patients and especially adolescents receiving 
immunomodulatory treatment for autoimmune disorders 
express concerns for their safety during the pandemic. Our 
experience is that a proportion of them has discontinued 
treatment on their own accord, because of their fear and uncer-
tainty about potential risks related to COVID-19. However, 
the limited available data do not support this; in a series of 
children receiving immunosuppression post-organ transplan-
tation, despite acquiring COVID-19, none of them became 
seriously ill (34).
7. Dermatology
The anxiety associated with the actual COVID-19 infection, as 
well as with the isolation and social distancing that people have 
to experience due to the pandemic, can be a potential cause for 
exacerbation of several chronic inflammatory skin conditions, 
especially those which are stress induced, like psoriasis, atopic 
dermatitis, rosacea and urticaria (35). Medication adherence, 
especially in psoriasis has been challenging (36), and could 
potentially deteriorate in the midst of the current COVID-19 
panic and misinformation in the social media (37), therefore 
providing clear guidance through efficient patient‑clinician 
communication is of critical importance.
Dermatologists need to remain alert and mindful of the 
significance of COVID-19. Special consideration should 
be given to high-risk patients with disease exacerbations, 
especially those on immunomodulatory medications (37). 
Clinicians should try to arrange safe monitoring, whilst at 
the same time avoiding unnecessary hospital visits. There is a 
need for accelerating the implementation of tele-dermatology, 
which has been shown to be effective (37).
8. Conclusions
The consequences of COVID-19 pandemic are multifaceted. 
The enormous individual and societal anxiety caused by this 
biothreat affects a wide spectrum of physical and mental 
pathologies and may even hamper their treatment. Remaining 
alert over the impact of the pandemic, retaining effective 
communication between clinicians of different specialties and 
patients, as well as introducing novel ways of clinical interac-
tion such as telemedicine, can assist to overcome the mounting 
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